12:47 EDT FDA announces apporval of Nuvation Bio’s (NUVB) Ibtrozi for lung cancer
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB:
- Nuvation Bio’s Strategic Positioning and Potential FDA Approval: Analyst Recommends Buy Rating
- Nuvation Bio Holds Successful Annual Meeting 2025
- Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength
- Buy Recommendation for Nuvation Bio: Promising Clinical Results and Strong Financial Position
- Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue